Revumenib Clinical Trials
Now Recruiting
A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation (AUGMENT-101).
A Study of SNDX-5613 in Combination With Chemotherapy in Participants With Leukemia (AUGMENT-102).